Cleared Traditional

K070082 - XY COR SPINAL IMPLANT FOR MINIMAL INVASIVE SPINAL SURGERY

K070082 is an FDA 510(k) clearance for XY COR SPINAL IMPLANT FOR MINIMAL INVAS..., manufactured by Vertebration,Inc. The device is a Class 2 Orthopedic device with product code MQP cleared through the Traditional 510(k) pathway after a 101-day FDA review.

K070082 · Vertebration,Inc · Orthopedic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2007
Decision
101d
Days
Class 2
Risk

K070082 is an FDA 510(k) clearance for the XY COR SPINAL IMPLANT FOR MINIMAL INVASIVE SPINAL SURGERY. Classified as Spinal Vertebral Body Replacement Device (product code MQP), Class II - Special Controls.

Submitted by Vertebration,Inc (Cincinnati, US). The FDA issued a Cleared decision on April 20, 2007 after a review of 101 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3060 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K070082

510(k) Number K070082 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 09, 2007
Decision Date April 20, 2007
Days to Decision 101 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 122d · This submission: 101d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQP Device Classification - Class 2, Special Controls

Product Code MQP Spinal Vertebral Body Replacement Device
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3060
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQP Spinal Vertebral Body Replacement Device

All 278
Devices cleared under the same product code (MQP) and FDA review panel - the closest regulatory comparables to K070082.
MODIFICATION TO: INTERPLATE VBR SYSTEM
K071372 · Rsb Spine, LLC · Jun 2007
VISTA -S DEVICE
K070382 · Zimmer Trabecular Metal Technology · May 2007
THEKEN VU MESH VBR SYSTEM
K070381 · Theken Spine, LLC · Apr 2007
INTERPLATE VBR SYSTEM
K070316 · Rsb Spine, LLC · Apr 2007
SINTEA BIOTECH DSC/ALF SPINAL SYSTEM, DSC.XX.T5.XX, ALF.XX.T5.XX
K070181 · Sintea Biotech, Inc. · Apr 2007
VERTIFLEX OCTANE PEEK VERTEBRAL BODY REPLACEMENT (PEEK VBR)
K070218 · Vertiflex (Tm), Incorporated · Apr 2007
K070082 · XY COR SPINAL IMPLANT FOR MINIMAL INVASIVE SPINAL SURGERY
Download PDF FDA Summary Vertebration,Inc